Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

New Data Retention Rules on the Horizon in Europe

Related Content

AI Voice Products Subject to California Invasion of Privacy Claims

Trump 2.0 Tech Policy Rundown: Breakneck Pace Continues

Protecting Children Online: EDPB Weighs in on Age Assurance Methods

Trump 2.0 Tech Policy Rundown: Breakneck Pace Continues

Tips for Maximizing Your Cyber Insurance Program

California Forges a New Path on Automated Decision-Making Technology, Risk Assessments, and Cybersecurity Audits

FTC Issues Long Awaited New COPPA Rules: How They Will Impact Your Business

UK Ransomware Consultation: Government Moves to Rein in Attacks

Cyber Counsel Group's 2025 Spring Conference

AI Security: Critical Questions, Expert Answers

Chambers Global 2025 Recognizes Goodwin Lawyers and Practices as Worldwide Leaders

NinjaOne, LLC to Acquire Dropsuite Limited

Goodwin CLE Week 2025

2024's Most Notable FTC Actions Against Dark Patterns And AI

Novo Holdings Completes $16.5 Billion Acquisition of Catalent

AlloVir and Kalaris Therapeutics to Merge

Data, Privacy & Cybersecurity

Strategic Technology Transactions and Licensing

Patent Prosecution & Counseling

Patent Litigation

Trademarks